Published in Obstet Gynecol on May 01, 2011
Duration of menopausal vasomotor symptoms over the menopause transition. JAMA Intern Med (2015) 3.44
Risk of long-term hot flashes after natural menopause: evidence from the Penn Ovarian Aging Study cohort. Menopause (2014) 1.75
Cross-cultural analysis of determinants of hot flashes and night sweats: Latin-American immigrants to Madrid and their Spanish neighbors. Menopause (2013) 1.38
The treatment of climacteric symptoms. Dtsch Arztebl Int (2012) 0.98
Management of Menopausal Symptoms. Obstet Gynecol (2015) 0.85
Risk factors for hot flashes among women undergoing the menopausal transition: baseline results from the Midlife Women's Health Study. Menopause (2015) 0.83
Trajectories of Vasomotor Symptoms and Carotid Intima Media Thickness in the Study of Women's Health Across the Nation. Stroke (2015) 0.79
Quality of life in female cancer survivors: is it related to ovarian reserve? Qual Life Res (2013) 0.78
Modeling Short- and Long-Term Characteristics of Follicle Stimulating Hormone as Predictors of Severe Hot Flashes in Penn Ovarian Aging Study. J R Stat Soc Ser C Appl Stat (2015) 0.78
Joint modeling of cross-sectional health outcomes and longitudinal predictors via mixtures of means and variances. Biometrics (2015) 0.78
Hot flashes are not predictive for serum concentrations of tamoxifen and its metabolites. BMC Cancer (2013) 0.78
Behavioral weight loss for the management of menopausal hot flashes: a pilot study. Menopause (2015) 0.77
Menopausal symptoms and cardiovascular disease mortality in the Women's Ischemia Syndrome Evaluation (WISE). Menopause (2016) 0.77
Changes in heart rate variability during vasomotor symptoms among midlife women. Menopause (2016) 0.76
Caring for the breast cancer survivor's health and well-being. World J Clin Oncol (2014) 0.75
Hot flashes and midlife symptoms in relation to levels of salivary cortisol. Maturitas (2016) 0.75
Perimenopause: From Research to Practice. J Womens Health (Larchmt) (2015) 0.75
The Relative Burden of Menopausal and Postmenopausal Symptoms versus Other Major Conditions: A Retrospective Analysis of the Medical Expenditure Panel Survey Data. Am Health Drug Benefits (2017) 0.75
Physiologically assessed hot flashes and endothelial function among midlife women. Menopause (2017) 0.75
Factors related to the experience of menopausal symptoms in women prescribed tamoxifen. J Psychosom Obstet Gynaecol (2016) 0.75
A global measure of perceived stress. J Health Soc Behav (1983) 56.90
Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep (1966) 48.83
Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA (2007) 10.50
A rating instrument for anxiety disorders. Psychosomatics (1974) 7.53
Longitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: study of women's health across the nation. Am J Public Health (2006) 4.51
Sleep difficulty in women at midlife: a community survey of sleep and the menopausal transition. Menopause (2003) 3.57
Executive summary: Stages of Reproductive Aging Workshop (STRAW). Climacteric (2001) 2.99
Graphical methods for assessing violations of the proportional hazards assumption in Cox regression. Stat Med (1995) 2.83
The role of anxiety and hormonal changes in menopausal hot flashes. Menopause (2005) 2.70
Symptoms associated with menopausal transition and reproductive hormones in midlife women. Obstet Gynecol (2007) 2.65
Revisiting the duration of vasomotor symptoms of menopause: a meta-analysis. J Gen Intern Med (2008) 2.64
Defining menopause status: creation of a new definition to identify the early changes of the menopausal transition. Menopause (2005) 2.50
Beyond frequency: who is most bothered by vasomotor symptoms? Menopause (2008) 2.35
Hot flashes and subclinical cardiovascular disease: findings from the Study of Women's Health Across the Nation Heart Study. Circulation (2008) 2.33
Depressed mood during the menopausal transition and early postmenopause: observations from the Seattle Midlife Women's Health Study. Menopause (2008) 2.22
Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause Society. Menopause (2004) 2.11
Obesity and reproductive hormone levels in the transition to menopause. Menopause (2010) 2.10
Health-related quality of life in a multiethnic sample of middle-aged women: Study of Women's Health Across the Nation (SWAN). Med Care (2003) 2.07
Hot flashes and cardiac vagal control: a link to cardiovascular risk? Menopause (2010) 2.02
Change in estradiol and follicle-stimulating hormone across the early menopausal transition: effects of ethnicity and age. J Clin Endocrinol Metab (2004) 2.00
Duration of vasomotor symptoms in middle-aged women: a longitudinal study. Menopause (2009) 1.86
Physiology of hot flashes. Am J Hum Biol (2001) 1.80
Gender differences in health care expenditures, resource utilization, and quality of care. J Manag Care Pharm (2008) 1.79
History of hot flashes and aortic calcification among postmenopausal women. Menopause (2010) 1.63
Frequency and severity of vasomotor symptoms among peri- and postmenopausal women in the United States. Climacteric (2008) 1.49
Follicular phase hormone levels and menstrual bleeding status in the approach to menopause. Fertil Steril (2005) 1.47
Adiposity and reporting of vasomotor symptoms among midlife women: the study of women's health across the nation. Am J Epidemiol (2007) 1.46
Evaluation and management of sleep disturbance during the menopause transition. Semin Reprod Med (2010) 1.39
Health care-seeking for menopausal problems. Climacteric (2003) 1.36
Menopausal symptoms in Australian women. Med J Aust (1993) 1.32
Menopause and sexuality: prevalence of symptoms and impact on quality of life. Maturitas (2009) 1.18
Predictors of first lifetime episodes of major depression in midlife women. Psychol Med (2008) 1.13
Hot flashes are associated with psychological symptoms of anxiety and depression in peri- and post- but not premenopausal women. Maturitas (2005) 1.12
Psychometric properties of a menopausal symptom list. Menopause (2003) 1.05
The relative role of gonadal sex steroids and gonadotropin-releasing hormone pulse frequency in the regulation of follicle-stimulating hormone secretion in men. J Clin Endocrinol Metab (2008) 1.03
Ethnicity and vasomotor symptoms in postmenopausal women. J Womens Health (Larchmt) (2007) 1.02
Role of ethnicity in the expression of features of hot flashes. Maturitas (2009) 0.99
Follicular arrest in polycystic ovary syndrome is associated with deficient inhibin A and B biosynthesis. J Clin Endocrinol Metab (2005) 0.99
Association of menopausal vasomotor symptoms with increased bone turnover during the menopausal transition. J Bone Miner Res (2011) 0.95
Healthcare use among U.S. women aged 45 and older: total costs and costs for selected postmenopausal health risks. J Womens Health Gend Based Med (1999) 0.92
Determinants of hot flashes and night sweats. Ann Hum Biol (2006) 0.87
Depressive symptoms and menopausal burden in the midlife. Maturitas (2009) 0.85
On hot flash mechanism, measurement, and treatment. Menopause (2009) 0.82
Vasomotor symptoms and depression in women, part I. Role of vasomotor symptoms in signaling the onset or relapse of a major depressive episode. J Clin Psychiatry (2009) 0.78
Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association. Circulation (2011) 5.26
BCR-ABL independence and LYN kinase overexpression in chronic myelogenous leukemia cells selected for resistance to STI571. Blood (2003) 3.86
Associations of hormones and menopausal status with depressed mood in women with no history of depression. Arch Gen Psychiatry (2006) 3.55
Hormones and menopausal status as predictors of depression in women in transition to menopause. Arch Gen Psychiatry (2004) 3.13
Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the American Heart Association. J Am Coll Cardiol (2011) 2.89
The role of anxiety and hormonal changes in menopausal hot flashes. Menopause (2005) 2.70
Efficacy of escitalopram for hot flashes in healthy menopausal women: a randomized controlled trial. JAMA (2011) 2.70
Symptoms associated with menopausal transition and reproductive hormones in midlife women. Obstet Gynecol (2007) 2.65
Defining menopause status: creation of a new definition to identify the early changes of the menopausal transition. Menopause (2005) 2.50
Presumed diagnosis of ectopic pregnancy. Obstet Gynecol (2002) 2.41
Maternal complications with vaginal birth after cesarean delivery: a multicenter study. Am J Obstet Gynecol (2005) 2.14
Obesity and reproductive hormone levels in the transition to menopause. Menopause (2010) 2.10
Acupuncture--help, harm, or placebo? Fertil Steril (2013) 2.02
Risk of venous thromboembolism in patients with cancer treated with Cisplatin: a systematic review and meta-analysis. J Clin Oncol (2012) 2.00
Janus kinase 2: a critical target in chronic myelogenous leukemia. Cancer Res (2006) 1.99
Body size affects measures of ovarian reserve in late reproductive age women. Menopause (2008) 1.93
Adverse neonatal outcomes: examining the risks between preterm, late preterm, and term infants. Am J Obstet Gynecol (2008) 1.92
Imatinib mesylate resistance through BCR-ABL independence in chronic myelogenous leukemia. Cancer Res (2004) 1.90
Symptomatic patients with an early viable intrauterine pregnancy: HCG curves redefined. Obstet Gynecol (2004) 1.88
Molecular engineering of DNA: molecular beacons. Angew Chem Int Ed Engl (2009) 1.84
Impact of therapeutic hypothermia onset and duration on survival, neurologic function, and neurodegeneration after cardiac arrest. Crit Care Med (2011) 1.81
A disintegrin and metalloprotease protein-12 as a novel marker for the diagnosis of ectopic pregnancy. Fertil Steril (2011) 1.76
Association of anti-mullerian hormone levels with obesity in late reproductive-age women. Fertil Steril (2006) 1.75
Risk of long-term hot flashes after natural menopause: evidence from the Penn Ovarian Aging Study cohort. Menopause (2014) 1.75
Anti-mullerian hormone as a predictor of time to menopause in late reproductive age women. J Clin Endocrinol Metab (2012) 1.67
Factors associated with patient, and diagnostic delays in Chinese TB patients: a systematic review and meta-analysis. BMC Med (2013) 1.61
Brief communication: physical abuse of boys and possible associations with poor adult outcomes. Ann Intern Med (2005) 1.55
Predictors of decreased libido in women during the late reproductive years. Menopause (2004) 1.54
Jak2 is involved in c-Myc induction by Bcr-Abl. Oncogene (2002) 1.54
Comparing postcesarean infectious complication rates using two different skin preparations. Obstet Gynecol (2011) 1.50
Keeping donor hearts in completely beating status with normothermic blood perfusion for transplants. Ann Thorac Surg (2013) 1.48
PI3K p110δ uniquely promotes gain-of-function Shp2-induced GM-CSF hypersensitivity in a model of JMML. Blood (2014) 1.48
Inhibition of lipocalin 2 impairs breast tumorigenesis and metastasis. Cancer Res (2009) 1.43
Hormones and sexuality during transition to menopause. Obstet Gynecol (2007) 1.42
Usefulness of pipelle endometrial biopsy in the diagnosis of women at risk for ectopic pregnancy. Am J Obstet Gynecol (2003) 1.39
Urinary incontinence and psychological distress in community-dwelling older adults. J Am Geriatr Soc (2002) 1.38
Antimullerian hormone and inhibin B are hormone measures of ovarian function in late reproductive-aged breast cancer survivors. Cancer (2010) 1.38
Interim analysis in clinical trials. Fertil Steril (2012) 1.37
Functionally significant SNP MMP8 promoter haplotypes and preterm premature rupture of membranes (PPROM). Hum Mol Genet (2004) 1.35
Evaluation of the association between hereditary thrombophilias and recurrent pregnancy loss: a meta-analysis. Arch Intern Med (2004) 1.32
Methods for the design of vasomotor symptom trials: the menopausal strategies: finding lasting answers to symptoms and health network. Menopause (2014) 1.31
Association between socio-psycho-behavioral factors and male semen quality: systematic review and meta-analyses. Fertil Steril (2010) 1.29
Impact of cancer therapies on ovarian reserve. Fertil Steril (2011) 1.28
A functional SNP in the promoter of the SERPINH1 gene increases risk of preterm premature rupture of membranes in African Americans. Proc Natl Acad Sci U S A (2006) 1.27
Treatment of localized periodontal disease in pregnancy does not reduce the occurrence of preterm birth: results from the Periodontal Infections and Prematurity Study (PIPS). Am J Obstet Gynecol (2010) 1.26
Predictors of prognosis in patients with olfactory disturbance. Ann Neurol (2008) 1.25
Temporal and spatial changes in transcription factor binding and histone modifications at the steroidogenic acute regulatory protein (stAR) locus associated with stAR transcription. Mol Endocrinol (2004) 1.22
Temporal associations of hot flashes and depression in the transition to menopause. Menopause (2009) 1.22
Decline of serum human chorionic gonadotropin and spontaneous complete abortion: defining the normal curve. Obstet Gynecol (2004) 1.21
Community health needs assessment with precede-proceed model: a mixed methods study. BMC Health Serv Res (2009) 1.20
The analysis of the drug-targets based on the topological properties in the human protein-protein interaction network. J Drug Target (2009) 1.20
Factors impacting the departure rates of female and male junior medical school faculty: evidence from a longitudinal analysis. J Womens Health (Larchmt) (2012) 1.19
Is vaginal birth after cesarean (VBAC) or elective repeat cesarean safer in women with a prior vaginal delivery? Am J Obstet Gynecol (2006) 1.19
Application of redefined human chorionic gonadotropin curves for the diagnosis of women at risk for ectopic pregnancy. Fertil Steril (2006) 1.17
Poor sleep in relation to natural menopause: a population-based 14-year follow-up of midlife women. Menopause (2015) 1.17
Risk factors for ectopic pregnancy in women with symptomatic first-trimester pregnancies. Fertil Steril (2006) 1.16
A deletion mutation in the betaA1/A3 crystallin gene ( CRYBA1/A3) is associated with autosomal dominant congenital nuclear cataract in a Chinese family. Hum Genet (2003) 1.16
Predictors of sleep quality in women in the menopausal transition. Sleep (2008) 1.16
Panel of markers can accurately predict endometriosis in a subset of patients. Fertil Steril (2007) 1.16
Human chorionic gonadotropin profile for women with ectopic pregnancy. Obstet Gynecol (2006) 1.14
Symptoms in the menopausal transition: hormone and behavioral correlates. Obstet Gynecol (2008) 1.14
Use of "2-dose" regimen of methotrexate to treat ectopic pregnancy. Fertil Steril (2006) 1.14
Performance of human chorionic gonadotropin curves in women at risk for ectopic pregnancy: exceptions to the rules. Fertil Steril (2012) 1.14
Molecular assembly of superquenchers in signaling molecular interactions. J Am Chem Soc (2005) 1.14
Periodontal disease and adverse pregnancy outcomes: is there an association? Am J Obstet Gynecol (2009) 1.14
Loss of Asxl1 leads to myelodysplastic syndrome-like disease in mice. Blood (2013) 1.12
Men's pathways to risky sexual behavior: role of co-occurring childhood sexual abuse, posttraumatic stress disorder, and depression histories. J Urban Health (2005) 1.11
Factors that influence entry into stages of the menopausal transition. Menopause (2009) 1.11
Semen quality of 1346 healthy men, results from the Chongqing area of southwest China. Hum Reprod (2008) 1.10
Does intracytoplasmic sperm injection improve the fertilization rate and decrease the total fertilization failure rate in couples with well-defined unexplained infertility? A systematic review and meta-analysis. Fertil Steril (2013) 1.10
The relationship between obesity and race on inhibin B during the menopause transition. Menopause (2005) 1.09
Overexpression of polo-like kinase1 predicts a poor prognosis in hepatocellular carcinoma patients. World J Gastroenterol (2009) 1.09
Menopause effects on verbal memory: findings from a longitudinal community cohort. J Clin Endocrinol Metab (2013) 1.07
The increased expression of IL-23 in inflammatory bowel disease promotes intraepithelial and lamina propria lymphocyte inflammatory responses and cytotoxicity. J Leukoc Biol (2011) 1.07